FIELD: medicine.
SUBSTANCE: invention relates to immunology. Disclosed are embodiments of using the recovered antibody or its antigen-binding site specific for B7-H1 in treating cancer. One of the embodiments of the use is characterized by the fact that antibody contains 6 CDR, while the other one - by the fact that the antibody contains a variable domain of a heavy and light chain.
EFFECT: invention provides extending the range of products for B7-H1 used in treating cancer.
12 cl, 15 dwg, 33 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SPECIFIC LINKING AGENTS AGAINST B7-H1 | 2010 |
|
RU2571204C2 |
| ANTIBODIES AGAINST 5-BROMO-2'-DEOXYURIDINE AND METHODS OF USE | 2015 |
|
RU2705299C2 |
| ANTI-PD-1 ANTIBODIES | 2017 |
|
RU2752832C2 |
| MONOVALENT CARRIER MODULES ACROSS BLOOD-BRAIN BARRIER | 2014 |
|
RU2694659C2 |
| THEOPHYLLINE ANTIBODIES AND METHODS FOR THEIR APPLICATION | 2013 |
|
RU2630664C2 |
| UNIVERSAL TRANSMITTER MODULES THROUGH THE HEMATOENCEPHALITIC BARRIER | 2014 |
|
RU2799436C1 |
| ANTIBODIES TO NKG2A AND THEIR APPLICATIONS | 2007 |
|
RU2499001C2 |
| ANTI-IGF-1R ANTIBODY AND USE THEREOF AS AN ADDRESS VECTOR FOR CANCER TREATMENT | 2015 |
|
RU2698977C2 |
| THERAPEUTIC DLL4-BINDING PROTEINS | 2010 |
|
RU2570639C2 |
| ANTIBODIES AGAINST A5 REPRESENTATIVE OF 19 FAMILY WITH SIMILARITY OF SEQUENCES AND THEIR APPLICATION METHOD | 2019 |
|
RU2785436C2 |
